THW (THW)

The abrdn World Healthcare Fund (THW) offers a 10.4% yield and trades at a 1.98% discount to NAV, making it attractive for income investors with its focus on biotechnology and pharmaceuticals. However, its distributions come from net realized gains, which could lead to NAV erosion during periods of loss. While monthly payouts suit income investors, capital appreciation is limited, and high interest rates may pressure future earnings.

This article provides a revenue breakdown for abrdn World Healthcare Fund Shares of Beneficial Interest (NYSE:THW), noting that the largest contribution to its revenue last year came from the United States, totaling $6.30 million USD. This figure is a decrease from $17.56 million USD the previous year. The data presented focuses on the top segments and regional performance.

Abrdn World Healthcare Fund announced it will go ex-dividend on July 23, 2026, with a dividend payout of $0.1167 per share. This declaration provides investors with crucial information regarding the upcoming dividend distribution.

Mahai Chris LaVictoire, a director of abrdn World Healthcare Fund (THW), purchased 796 shares of Common Stock on July 16, 2026, at $13.20 per share. This open-market transaction increased his direct ownership to 796 shares of the fund's Common Stock, valued at approximately $11,000. The filing, categorized as neutral in impact and positive in sentiment, highlights a direct investment by a company insider.

Mahai Chris LaVictoire, a director at abrdn World Healthcare Fund, purchased 796 common shares at $13.2 each, totaling $10,507.2. After this transaction, LaVictoire's direct holdings amount to 796 common shares. This information is based on a report filed via EDGAR with the U.S. Securities and Exchange Commission.